ID   DHB3_RAT                Reviewed;         306 AA.
AC   O54939;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   02-OCT-2024, entry version 142.
DE   RecName: Full=17-beta-hydroxysteroid dehydrogenase type 3;
DE            Short=17-beta-HSD 3;
DE   AltName: Full=Estradiol 17-beta-dehydrogenase 2;
DE            EC=1.1.1.62 {ECO:0000250|UniProtKB:P37058};
DE   AltName: Full=Testicular 17-beta-hydroxysteroid dehydrogenase;
DE   AltName: Full=Testosterone 17-beta-dehydrogenase 3 {ECO:0000305};
DE            EC=1.1.1.64 {ECO:0000250|UniProtKB:P37058};
GN   Name=Hsd17b3 {ECO:0000312|RGD:621805}; Synonyms=Edh17b3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Khanum A., Tsai-Morris C.-H., Dufau M.L.;
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Catalyzes the conversion of 17-oxosteroids to 17beta-
CC       hydroxysteroids. Favors the reduction of androstenedione to
CC       testosterone. Testosterone is the key androgen driving male development
CC       and function (By similarity). Uses NADPH while the two other EDH17B
CC       enzymes use NADH. Androgens such as epiandrosterone,
CC       dehydroepiandrosterone, androsterone and androstanedione are accepted
CC       as substrates and reduced at C-17. Can reduce 11-ketoandrostenedione as
CC       well as 11beta-hydroxyandrostenedione at C-17 to the respective
CC       testosterone forms (By similarity). Plays a role in the rate-limiting-
CC       step for the maximum level of testosterone production by the testis but
CC       does not affect basal testosterone production (By similarity).
CC       {ECO:0000250|UniProtKB:P37058, ECO:0000250|UniProtKB:P70385}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 17beta-hydroxy steroid + NADP(+) = a 17-oxo steroid + H(+) +
CC         NADPH; Xref=Rhea:RHEA:69284, ChEBI:CHEBI:15378, ChEBI:CHEBI:19168,
CC         ChEBI:CHEBI:35343, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:69286;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADP(+) + testosterone = androst-4-ene-3,17-dione + H(+) +
CC         NADPH; Xref=Rhea:RHEA:14981, ChEBI:CHEBI:15378, ChEBI:CHEBI:16422,
CC         ChEBI:CHEBI:17347, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.64;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:14983;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-estradiol + NADP(+) = estrone + H(+) + NADPH;
CC         Xref=Rhea:RHEA:24616, ChEBI:CHEBI:15378, ChEBI:CHEBI:16469,
CC         ChEBI:CHEBI:17263, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.62;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:24618;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3beta-hydroxyandrost-5-en-17-one + H(+) + NADPH = androst-5-
CC         en-3beta,17beta-diol + NADP(+); Xref=Rhea:RHEA:46628,
CC         ChEBI:CHEBI:2710, ChEBI:CHEBI:15378, ChEBI:CHEBI:28689,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46629;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-hydroxy-5alpha-androstan-3-one + NADP(+) = 5alpha-
CC         androstan-3,17-dione + H(+) + NADPH; Xref=Rhea:RHEA:42120,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15994, ChEBI:CHEBI:16330,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:42122;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=androsterone + H(+) + NADPH = 5alpha-androstane-3alpha,17beta-
CC         diol + NADP(+); Xref=Rhea:RHEA:42156, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16032, ChEBI:CHEBI:36713, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; Evidence={ECO:0000250|UniProtKB:P37058};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42157;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3beta-hydroxy-5alpha-androstan-17-one + H(+) + NADPH = 5alpha-
CC         androstane-3beta,17beta-diol + NADP(+); Xref=Rhea:RHEA:53480,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:18329, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:541975;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53481;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=androst-4-ene-3,11,17-trione + H(+) + NADPH = 17beta-
CC         hydroxyandrost-4-ene-3,11-dione + NADP(+); Xref=Rhea:RHEA:53484,
CC         ChEBI:CHEBI:2495, ChEBI:CHEBI:15378, ChEBI:CHEBI:34133,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53485;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=11beta-hydroxyandrost-4-ene-3,17-dione + H(+) + NADPH =
CC         11beta,17beta-dihydroxyandrost-4-ene-3-one + NADP(+);
CC         Xref=Rhea:RHEA:53488, ChEBI:CHEBI:15378, ChEBI:CHEBI:27967,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:81481;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53489;
CC         Evidence={ECO:0000250|UniProtKB:P37058};
CC   -!- PATHWAY: Hormone biosynthesis; testosterone biosynthesis.
CC       {ECO:0000250|UniProtKB:P37058}.
CC   -!- PATHWAY: Steroid metabolism. {ECO:0000250|UniProtKB:P37058}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P37058}.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC       family. 17-beta-HSD 3 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF035156; AAB99739.1; -; mRNA.
DR   RefSeq; NP_446459.1; NM_054007.1.
DR   AlphaFoldDB; O54939; -.
DR   SMR; O54939; -.
DR   STRING; 10116.ENSRNOP00000025850; -.
DR   BindingDB; O54939; -.
DR   ChEMBL; CHEMBL1075158; -.
DR   DrugCentral; O54939; -.
DR   iPTMnet; O54939; -.
DR   PhosphoSitePlus; O54939; -.
DR   PaxDb; 10116-ENSRNOP00000025850; -.
DR   GeneID; 117182; -.
DR   KEGG; rno:117182; -.
DR   UCSC; RGD:621805; rat.
DR   AGR; RGD:621805; -.
DR   CTD; 3293; -.
DR   RGD; 621805; Hsd17b3.
DR   eggNOG; KOG1014; Eukaryota.
DR   InParanoid; O54939; -.
DR   OrthoDB; 6845at2759; -.
DR   PhylomeDB; O54939; -.
DR   BRENDA; 1.1.1.51; 5301.
DR   BRENDA; 1.1.1.64; 5301.
DR   Reactome; R-RNO-193048; Androgen biosynthesis.
DR   Reactome; R-RNO-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   UniPathway; UPA00367; -.
DR   PRO; PR:O54939; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0072582; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; IEA:RHEA.
DR   GO; GO:0004303; F:estradiol 17-beta-dehydrogenase [NAD(P)+] activity; IDA:RGD.
DR   GO; GO:0047045; F:testosterone 17-beta-dehydrogenase (NADP+) activity; ISS:UniProtKB.
DR   GO; GO:0047035; F:testosterone dehydrogenase (NAD+) activity; IDA:RGD.
DR   GO; GO:0018879; P:biphenyl metabolic process; IEP:RGD.
DR   GO; GO:0071236; P:cellular response to antibiotic; IEP:RGD.
DR   GO; GO:0071371; P:cellular response to gonadotropin stimulus; IEP:RGD.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; IEP:RGD.
DR   GO; GO:0021766; P:hippocampus development; IEP:RGD.
DR   GO; GO:0017143; P:insecticide metabolic process; IEP:RGD.
DR   GO; GO:0033327; P:Leydig cell differentiation; IEP:RGD.
DR   GO; GO:0006082; P:organic acid metabolic process; IEP:RGD.
DR   GO; GO:0018958; P:phenol-containing compound metabolic process; IEP:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0046685; P:response to arsenic-containing substance; IEP:RGD.
DR   GO; GO:0046686; P:response to cadmium ion; IEP:RGD.
DR   GO; GO:0051412; P:response to corticosterone; IEP:RGD.
DR   GO; GO:0043627; P:response to estrogen; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0070542; P:response to fatty acid; IEP:RGD.
DR   GO; GO:0060992; P:response to fungicide; IEP:RGD.
DR   GO; GO:0009635; P:response to herbicide; IEP:RGD.
DR   GO; GO:0017085; P:response to insecticide; IEP:RGD.
DR   GO; GO:0033591; P:response to L-ascorbic acid; IEP:RGD.
DR   GO; GO:0010288; P:response to lead ion; IEP:RGD.
DR   GO; GO:0010038; P:response to metal ion; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; IEP:RGD.
DR   GO; GO:0033197; P:response to vitamin E; IEP:RGD.
DR   GO; GO:0006694; P:steroid biosynthetic process; IDA:RGD.
DR   GO; GO:0061370; P:testosterone biosynthetic process; IEA:UniProtKB-UniPathway.
DR   CDD; cd05356; 17beta-HSD1_like_SDR_c; 1.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR002347; SDR_fam.
DR   InterPro; IPR051019; VLCFA-Steroid_DH.
DR   PANTHER; PTHR43899:SF7; 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3; 1.
DR   PANTHER; PTHR43899; RH59310P; 1.
DR   Pfam; PF00106; adh_short; 1.
DR   PIRSF; PIRSF000126; 11-beta-HSD1; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
PE   2: Evidence at transcript level;
KW   Endoplasmic reticulum; Lipid biosynthesis; Lipid metabolism; NADP;
KW   Oxidoreductase; Reference proteome; Steroid biosynthesis.
FT   CHAIN           1..306
FT                   /note="17-beta-hydroxysteroid dehydrogenase type 3"
FT                   /id="PRO_0000054575"
FT   ACT_SITE        194
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   BINDING         44..73
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         181
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   306 AA;  34223 MW;  8B88584047614B53 CRC64;
     MEQFLLSVGL LVCLVCLVKC VRFSRYLFLS FCKALPGSFL RSMGQWAVIT GAGDGIGKAY
     SFELARHGLN VVLISRTLEK LQVISEEIER TTGSRVKVVQ ADFTREDIYD HIEEQLKGLE
     IGVLVNNVGM LPNLLPSHFL STSGESQSVI HCNITSVVKM TQLVLKHMES RRRGLILNIS
     SGVGVRPWPL YSLYSASKAF VCTFSKALNV EYRDKGIIIQ VLTPYSVSTP MTKYLNTSRV
     TKTADEFVKE SLKYVTIGAE TCGCLAHEIL AIILNLIPSR IFYSSTTQRF LLKQFSDYLK
     SNISNR
//
